Menu
About Us
Overview
Board
Team
Corporate Directory
Our Science
Gene Silencing
Intellectual Property
Partnering
Our Programs
Areas of Research
Pipeline
Out-Licensed Programs
Presentations and Publications
For Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Contact Us
Financial Information
Investors
Investors
Overview
News & Events
Overview
Press Releases
Events
Media Coverage
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Annual Reports
Form 8937 – Reverse Stock Split
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Financial Info
Overview
Financial Results
Annual Reports
Form 8937 – Reverse Stock Split
Latest Financial Results
FY 2023
Fiscal Year Ended Jun 30, 2023
Earnings Release
PDF
HTML
10-K
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Latest 10-K
View HTML
View PDF
Financials
View the latest financials
Balance Sheet
Income Statement
Cash Flow
Email Alerts
Contacts
RSS News Feed